Hybrid capture II and PapilloCheck® tests for detection of anal high-risk human papillomavirus

AUTOR(ES)

Maia, Livia Bravo, Marinho, Larissa Cardoso, Bocca, Anamélia Lorenzetti, Cavalcante Neto, Florêncio Figueiredo, Velasco, Lara Franciele Ribeiro, Costa, Patrícia Godoy Garcia, Carneiro, Fabiana Pirani, Oliveira, Paulo Gonçalves de

FONTE

Rev. Soc. Bras. Med. Trop.

DATA DE PUBLICAÇÃO

2014-04

RESUMO

Introduction This study evaluated the level of concordance between hybrid capture II (HCII) and PapilloCheck® for the detection of high-risk human papillomavirus (HPV) in anal samples. Methods Anal cell samples collected from 42 human immunodeficiency virus (HIV)+ patients were analyzed. Results Considering only the 13 high-risk HPV types that are detectable by both tests, HCII was positive for 52.3% of the samples, and PapilloCheck® was positive for 52.3%. The level of concordance was 80.9% (Kappa = 0.61). Conclusions Good concordance was observed between the tests for the detection of high-risk HPV.

Documentos Relacionados

• Anal High-risk HPV and Liquid-based Cytology of Immunocompetent Brazilian Women with Genital High-risk HPV
• Oncogenic high-risk human papillomavirus in patients with full denture
• Characterization of the high-risk human papillomavirus infection in Jining, China
• Detection of high risk human papillomavirus cervical infections by the hybrid capture in Asunción, Paraguay
• Prevalence of high-risk human papillomavirus by cobas 4800 HPV test in urban Peru